Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 1,206,707 | 1,793,866 | +587,159 | $71.40M | $89.62M | 31.75% | +$18.22M |
| Stoke Therapeutics, Inc.(STOK) | 5,185,191 | 5,187,191 | +2,000 | $70.05M | $63.75M | 22.59% | -$6.30M |
| C4 Therapeutics, Inc.(CCCC) | 6,880,527 | 6,880,527 | 0 | $31.79M | $39.22M | 13.90% | +$7.43M |
| GH Research PLC(GHRS) | 3,966,726 | 4,195,894 | +229,168 | $46.25M | $28.07M | 9.95% | -$18.18M |
| TScan Therapeutics, Inc.(TCRX) | 5,224,600 | 5,224,600 | 0 | $30.56M | $26.02M | 9.22% | -$4.55M |
| Allogene Therapeutics Inc | 2,228,295 | 6,202,374 | +3,974,079 | $5.19M | $17.37M | 6.15% | +$12.17M |
| Cullinan Therapeutics, Inc.(CGEM) | 377,323 | 410,830 | +33,507 | $6.58M | $6.88M | 2.44% | +$296.8K |
| Passage Bio, Inc.(PASG) | 5,057,629 | 8,426,955 | +3,369,326 | $4.02M | $5.90M | 2.09% | +$1.88M |
| iBio, Inc.CON NEW(IBIO) | 600,000 | 862,279 | +262,279 | $1.27M | $1.91M | 0.68% | +$648.3K |
| Caribou Biosciences, Inc.(CRBU) | 0 | 680,189 | +680,189 | $0 | $1.33M | 0.47% | +$1.33M |
| Kodiak Sciences Inc.(KOD) | 0 | 271,177 | +271,177 | $0 | $707.8K | 0.25% | +$707.8K |
| Pieris Pharmaceuticals Inc | 43,499 | 37,436 | -6,063 | $426.8K | $620.7K | 0.22% | +$193.9K |
| Centessa Pharmaceuticals PlcADS | 17,400 | 17,400 | 0 | $157.1K | $278.2K | 0.10% | +$121.1K |
| Bionomics LimitedADS | 599,673 | 549,673 | -50,000 | $459.9K | $241.5K | 0.09% | -$218.5K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 9,500 | 8,231 | -1,269 | $177.4K | $205.7K | 0.07% | +$28.3K |
| Tenax Therapeutics, Inc.(TENX) | 0 | 14,751 | +14,751 | $0 | $51.0K | 0.02% | +$51.0K |
| Century Therapeutics, Inc.(IPSC) | 0 | 19,028 | +19,028 | $0 | $32.5K | 0.01% | +$32.5K |
| Yarrow Bioscience Inc(YARW) | 16,194 | 16,194 | 0 | $31.9K | $30.4K | 0.01% | -$1.5K |
| Cabaletta Bio, Inc.(CABA) | 492,103 | 0 | -492,103 | $3.68M | $0 | — | -$3.68M |
| Korro Bio, Inc.(KRRO) | 3,800 | 0 | -3,800 | $128.7K | $0 | — | -$128.7K |
| Longboard Pharmaceuticals In | 167,317 | 0 | -167,317 | $4.52M | $0 | — | -$4.52M |